Literature DB >> 12692589

IGF-I gene transfer by electroporation promotes regeneration in a muscle injury model.

T Takahashi1, K Ishida, K Itoh, Y Konishi, K-I Yagyu, A Tominaga, J-I Miyazaki, H Yamamoto.   

Abstract

The goal of this study was to determine whether insulin-like growth factor-I (IGF-I) gene delivery by electroporation promotes repair after muscle injury. An injury-repair model was created using mice in which a hamstring muscle was cut and sutured. A total of 50 microg of IGF-I DNA or green fluorescent protein (GFP) DNA (both in pCAGGS) was injected into the lesion and introduced into muscle cells by electrostimulation using an electric pulse generator. The number of regenerating muscle fibers in the IGF-I DNA group was significantly more than that in the GFP DNA group at 2 weeks after injection. The diameter of regenerating muscle fibers from the IGF-I DNA group was larger than that of the GFP DNA group at 4 weeks after injection. There was no significant difference in the serum IGF-I concentration between the IGF-I DNA group and the GFP DNA group at 1, 2, and 4 weeks after injection. However, muscle IGF-I concentration in the IGF-I DNA injection group was significantly greater than that in the GFP DNA injection group at 2 weeks after injection. These results demonstrated that the effects of enhanced IGF-I production were local and limited to the injected area. The ratio (injected/uninjected; intact) of the amplitude of compound muscle action potentials (CMAP) in the IGF-I DNA injection group was greater than that in the GFP DNA injection group at 4 weeks after injection and of the control group. In conclusion, IGF-I gene transfer by electroporation proved to be a simple, safe, inexpensive, and effective method to promote the regeneration of injured muscles in our injury model.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692589     DOI: 10.1038/sj.gt.3301900

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  6 in total

1.  Enhanced athletic performance on multisite AAV-IGF1 gene transfer coincides with massive modification of the muscle proteome.

Authors:  Antero Macedo; Manuela Moriggi; Michele Vasso; Sara De Palma; Mauro Sturnega; Giorgio Friso; Cecilia Gelfi; Mauro Giacca; Serena Zacchigna
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

2.  Impact of intramuscular administration of lipid-soluble and water-soluble vehicles into regenerating muscle at the distinct phases of skeletal muscle regeneration.

Authors:  Ratchakrit Srikuea; Kanokwan Suhatcho
Journal:  J Physiol Sci       Date:  2017-11-13       Impact factor: 2.781

Review 3.  Optimizing IGF-I for skeletal muscle therapeutics.

Authors:  Anastassios Philippou; Elisabeth R Barton
Journal:  Growth Horm IGF Res       Date:  2014-06-19       Impact factor: 2.372

4.  Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.

Authors:  James P White; Kristen A Baltgalvis; Shuichi Sato; L Britt Wilson; James A Carson
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

Review 5.  Treatment of skeletal muscle injury: a review.

Authors:  L Baoge; E Van Den Steen; S Rimbaut; N Philips; E Witvrouw; K F Almqvist; G Vanderstraeten; L C Vanden Bossche
Journal:  ISRN Orthop       Date:  2012-04-26

6.  BIOMECHANICAL AND HISTOLOGICAL ANALYSIS OF THE GASTROCNEMIUS IN RATS SUBJECTED TO MUSCLE INJURY AND TREATMENT WITH LOW-LEVEL LASER THERAPY.

Authors:  Mauricio José Falcai; Vanessa Vilela Monte-Raso; Rodrigo Okubo; Ariane Zamarioli; Leonardo César Carvalho; Antõnio Carlos Shimano
Journal:  Rev Bras Ortop       Date:  2015-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.